STAT News · Scour

STAT+: Pharmalittle: We’re reading about FDA seeking new powers over DTC ads, an EU pledge to fight AMR, and more

statnews.com·5w

STAT+: Are AI scribes actually driving higher health care costs?

statnews.com·5w

What does MAHA look like these days?

statnews.com·5w

STAT+: Everyone agrees AI scribes are increasing health care costs. No one agrees what to do about it

statnews.com·5w

Opinion: How sports betting is hooking some young men

statnews.com·5w

STAT+: A decade ago, these drugs tore apart the FDA. Today, they might be some patients’ best hope

statnews.com·5w

Opinion: What American hospitals can learn from India about waste

statnews.com·5w

Judge refuses to block sending abortion pill by mail for now, but says FDA must finish review

statnews.com·5w

STAT+: Novo Nordisk launches high-dose Wegovy

statnews.com·5w

STAT+: States looking to regulate use of chatbots

statnews.com·5w

STAT+: Trump budget’s ‘America First’ drug policy proposals

statnews.com·5w

STAT+: Many cancer patients don’t get genomic tests to guide treatment, study finds

statnews.com·5w

STAT+: Pharmalittle: We’re reading about FDA backing domestic production, another Gilead deal, and more

statnews.com·5w

If you cap insulin at $35 a month, people with type 2 diabetes stick to treatment, study finds

statnews.com·5w

STAT+: Gilead to buy cancer biotech Tubulis for more than $3B

statnews.com·5w

STAT+: Merck’s experimental HIV prevention pill could be made for less than $5 a year, researchers say

statnews.com·5w

Opinion: How the insurance system quietly undoes recovery from addiction

statnews.com·5w

STAT+: University of Michigan wins 2026 STAT Madness for new insights into abdominal aortic aneurysms

statnews.com·5w

Opinion: STAT+: Former Geisinger CEO: U.S. health systems must replace huge numbers of people with AI

statnews.com·5w

STAT+: FDA backs proposals to entice pharma companies to test, make drugs domestically

statnews.com·5w

Log in to enable infinite scrolling